Skip to main content
. 2023 Mar 14;11(3):653. doi: 10.3390/vaccines11030653

Table 3.

Negative T-SPOT results for COVID-19.

Control (%) HD (%) p Value
2–6 M 66.7 * 43.1 § 0.02
3–3 W 35.0 29.0 0.66
3–3 M 37.2 24.2 0.19

2–6 M: 6 months after the primary series. 3–3 W: 3 weeks after the booster dose. 3–3 M: 3 months after the booster dose. COVID-19: coronavirus disease 2019. HD: Hemodialysis. * n = 45; n = 40; n = 43; § n = 65; n = 63; n = 62. The correlations between the T-SPOT results and antibody titers of each of the three measurement points in each group were evaluated (Figure 4). No significant correlations were observed at 6 months after the primary series, 3 weeks after the booster dose, or 3 months after the booster dose.